Board of Directors

James A. Geraghty
Chairman of the Board

Jim Geraghty has been a director of the Company since May 2015 and was elected Chairman of the Board in July 2015. He is an industry leader with 30 years of strategic and leadership experience, including more than 20 years as a senior member of executive teams at biotechnology companies developing and commercializing innovative therapies. Mr. Geraghty serves as Chairman of the Board of Idera Pharmaceuticals. He also serves a director on the Boards of Pieris Pharmaceuticals, Inc., Fulcrum Therapeutics, Inc., Voyager Therapeutics, Inc., and BIO Ventures for Global Health.

Earlier, Mr. Geraghty served as an Entrepreneur in Residence at Third Rock Ventures, a leading biotech venture and company-formation fund. He served as Senior Vice President, North America Strategy and Business Development at Sanofi, which he joined upon its acquisition of Genzyme. Mr. Geraghty spent 20 prior years at Genzyme, where his roles included Senior Vice President International Development, President of Genzyme Europe, and General Manager of Genzyme's cardiovascular business. Mr. Geraghty also oversaw Genzyme's Humanitarian Assistance for Neglected Diseases (HAND) program, under which the company supported innovative development programs on a non-commercial basis.

He started his career in healthcare strategy consulting at Bain and Company. A graduate of the Yale Law School, Mr. Geraghty holds a M.S. from the University of Pennsylvania and a B.A. from Georgetown University.

Chairman of the Board